Skip to main content
Clinical Trials/IRCT20141209020258N117
IRCT20141209020258N117
Recruiting
Phase 2

Comparison Intraperitoneal Ropivacaine alone and with Dexmedetomidin and Fentanyl on pain management in abdominal laparoscopic

Arak University of Medical Sciences0 sites138 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Arak University of Medical Sciences
Enrollment
138
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients candidate laparoscopic abdominal surgery
  • 18 to 65 years old
  • No susceptibility to used drugs
  • Absence of cardiovascular disease and endocrine and renal disease
  • No smoking and no addiction
  • No pregnancy
  • Body mass index more than 35

Exclusion Criteria

  • No willingness to continue the study
  • Refusal of the patient to inject intraperitoneally
  • Patient that requires the insertion of a drain inside the abdomen for any reason

Outcomes

Primary Outcomes

Not specified

Similar Trials